Rate My Professor Elaine Bignell

Bignell's research specializations centre on the pathobiology of human fungal infections, particularly lung infections caused by environmental moulds like Aspergillus fumigatus. Her academic interests include fungal pathogenicity mechanisms, signal transduction in fungal cells, and antifungal drug resistance. Her contributions have informed therapeutic strategies for fatal fungal infections in immunocompromised patients with cancer, HIV, or organ transplants. A key discovery is a fungal protein sensing extracellular pH, now targeted for novel antifungals. In 2024, she leads a £3.2 million MRC Programme grant to preserve antifungal drug efficacy. Recognised with election as Fellow of the American Academy of Microbiology in 2023, her work has over 7,000 Google Scholar citations. Key publications include "Tackling the emerging threat of antifungal resistance to human health" (Nature Reviews Microbiology, 2022), "The pathobiology of human fungal infections" (2024), and "Functional analysis of the Aspergillus fumigatus kinome reveals an essential role for the protein kinase A pathway in virulence" (2023). She is a founding Management Board member of the CMM LATAM Unit (2023) and contributes to public engagement on fungal threats.